Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIVARACETAM | 75MG | TABLET | Resolved | 2025-01-23 | 2025-02-14 | 248486 |
| APO-BRIVARACETAM | 50MG | TABLET | Resolved | 2025-01-09 | 2025-02-14 | 247388 |
| APO-BROMAZEPAM | 3MG | TABLET | Resolved | 2024-10-18 | 2024-10-25 | 240699 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | Resolved | 2018-05-15 | 2018-08-28 | 49484 |
| APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2024-01-19 | 2024-03-22 | 216678 |
| APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2023-12-01 | 2024-01-05 | 212389 |
| APO-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-01-26 | 2024-02-02 | 217484 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170109 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-05-12 | 184072 |
| APO-BUSPIRONE - TAB 10MG | 10MG | TABLET | Resolved | 2017-05-24 | 2017-06-27 | 11056 |
| APO-BUSPIRONE - TAB 10MG | 10MG | TABLET | Resolved | 2021-01-29 | 2021-03-24 | 132706 |
| APO-BUSPIRONE - TAB 10MG | 10MG | TABLET | Resolved | 2017-10-23 | 2017-11-20 | 26564 |
| APO-CABERGOLINE | 0.5MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213587 |
| APO-CABERGOLINE | 0.5MG | TABLET | Resolved | 2024-01-12 | 2024-10-10 | 215982 |
| APO-CABERGOLINE | 0.5MG | TABLET | Resolved | 2018-02-26 | 2021-03-02 | 41136 |
| APO-CANDESARTAN | 16MG | TABLET | Resolved | 2018-01-03 | 2020-02-25 | 34838 |
| APO-CANDESARTAN | 4MG | TABLET | Resolved | 2020-10-21 | 2021-03-15 | 126768 |
| APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2022-03-11 | 2022-03-11 | 156534 |
| APO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166589 |
| APO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166592 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CAP 250MG | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI CAP 500MG | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |